Published in J Virol on April 22, 2009
Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature (2010) 2.87
The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production. J Virol (2014) 1.22
Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: past, present and future. Viruses (2012) 1.12
The curious case of arenavirus entry, and its inhibition. Viruses (2012) 1.11
Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses (2010) 1.11
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology (2011) 1.10
Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J Virol (2011) 1.06
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever. PLoS Negl Trop Dis (2011) 1.03
Molecular determinants of Pichinde virus infection of guinea pigs--a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci (2009) 0.97
In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions. J Virol (2015) 0.96
Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence. J Virol (2011) 0.90
A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose. J Virol (2015) 0.88
Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses. Antimicrob Agents Chemother (2011) 0.85
Biological roles and functional mechanisms of arenavirus Z protein in viral replication. J Virol (2012) 0.85
Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus. Virology (2012) 0.84
Identification of virulence determinants within the L genomic segment of the pichinde arenavirus. J Virol (2013) 0.84
Arenavirus reverse genetics for vaccine development. J Gen Virol (2013) 0.83
Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain. J Virol (2015) 0.83
Molecular mechanism of arenavirus assembly and budding. Viruses (2012) 0.83
Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opin Drug Discov (2012) 0.82
Comparative pathogenesis and systems biology for biodefense virus vaccine development. J Biomed Biotechnol (2010) 0.82
Proteomic analysis of Pichindé virus infection identifies differential expression of prothymosin-alpha. J Biomed Biotechnol (2010) 0.80
Uncovering viral protein-protein interactions and their role in arenavirus life cycle. Viruses (2012) 0.77
Reverse Genetics Approaches to Control Arenavirus. Methods Mol Biol (2016) 0.75
Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence. J Virol (2016) 0.75
Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses (2016) 0.75
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J Infect Dis (1980) 2.38
Lassa virus. Crit Rev Clin Lab Sci (2004) 2.27
Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog (2008) 2.23
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol (2002) 1.97
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A (2006) 1.79
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol (2001) 1.66
Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology (2006) 1.58
Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. Rev Infect Dis (1989) 1.58
Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol (2003) 1.56
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun (1981) 1.51
Pathogenesis of Lassa virus infection in guinea pigs. Infect Immun (1982) 1.47
A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J Virol (2005) 1.42
Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J Virol (2007) 1.41
The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest (1977) 1.41
Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology (1991) 1.35
Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology (1989) 1.25
Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains. Am J Pathol (1994) 1.25
Alterations in NF-kappaB and RBP-Jkappa by arenavirus infection of macrophages in vitro and in vivo. J Virol (2002) 1.24
Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol (1986) 1.22
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Lassa fever vaccine. Expert Rev Vaccines (2004) 1.08
Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J Virol (2006) 1.07
Sequence analysis of the small RNA segment of guinea pig-passaged Pichinde virus variants. Am J Trop Med Hyg (1999) 1.07
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology (2006) 1.06
Mutational analysis of the lassa virus promoter. J Virol (2006) 1.06
Reassortant analysis of guinea pig virulence of pichinde virus variants. Virology (2001) 1.02
Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs. Am J Trop Med Hyg (1995) 1.01
Genome comparison of virulent and avirulent strains of the Pichinde arenavirus. Arch Virol (2008) 1.01
The effect of an arenavirus infection on liver morphology and function. Am J Trop Med Hyg (1990) 0.96
Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study. Am J Trop Med Hyg (1993) 0.95
Reverse genetics of arenaviruses. Curr Top Microbiol Immunol (2002) 0.94
Cardiovascular and pulmonary responses to Pichinde virus infection in strain 13 guinea pigs. Lab Anim Sci (1994) 0.91
Pichinde virus infection in strain 13 guniea pigs reduces intestinal protein reflection coefficient with compensation. J Infect Dis (1990) 0.82
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature (2010) 2.87
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. J Infect Dis (2007) 2.74
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol (2003) 2.60
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology (2010) 2.55
Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes. J Virol (2005) 2.29
Expression of conjoined genes: another mechanism for gene regulation in eukaryotes. PLoS One (2010) 2.13
Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. Eur J Gastroenterol Hepatol (2016) 2.06
A universal telomerase RNA core structure includes structured motifs required for binding the telomerase reverse transcriptase protein. Proc Natl Acad Sci U S A (2004) 1.83
Mutational analyses of packaging signals in influenza virus PA, PB1, and PB2 genomic RNA segments. J Virol (2007) 1.72
Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana. Indian Heart J (2004) 1.57
Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood (2006) 1.57
Complete genome sequences of rat and mouse segmented filamentous bacteria, a potent inducer of th17 cell differentiation. Cell Host Microbe (2011) 1.46
Defective assembly of influenza A virus due to a mutation in the polymerase subunit PA. J Virol (2006) 1.45
Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: a case series. Indian J Gastroenterol (2014) 1.42
NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol (2008) 1.38
Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol Biol Cell (2008) 1.22
The RNA-binding protein SUP-12 controls muscle-specific splicing of the ADF/cofilin pre-mRNA in C. elegans. J Cell Biol (2004) 1.18
Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol (2013) 1.17
Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J Biol Chem (2013) 1.15
In vitro and in vivo efficacy of β-lactams against replicating and slowly growing/nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother (2013) 1.10
T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A (2011) 1.07
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia. Exp Hematol (2006) 1.03
Fast and accurate taxonomic assignments of metagenomic sequences using MetaBin. PLoS One (2012) 1.02
Genome comparison of virulent and avirulent strains of the Pichinde arenavirus. Arch Virol (2008) 1.01
Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors. Anticancer Res (2004) 1.00
Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol (2011) 0.99
MetaBioME: a database to explore commercially useful enzymes in metagenomic datasets. Nucleic Acids Res (2009) 0.98
Molecular determinants of Pichinde virus infection of guinea pigs--a small animal model system for arenaviral hemorrhagic fevers. Ann N Y Acad Sci (2009) 0.97
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo. J Med Chem (2013) 0.97
Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells. J Virol (2010) 0.96
Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever. Antiviral Res (2012) 0.95
MAAP: malarial adhesins and adhesin-like proteins predictor. Proteins (2008) 0.95
Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model. Antimicrob Agents Chemother (2012) 0.93
The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology (2013) 0.92
Abundance of dinucleotide repeats and gene expression are inversely correlated: a role for gene function in addition to intron length. Physiol Genomics (2007) 0.90
Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China. Am J Trop Med Hyg (2008) 0.89
Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. J Vasc Surg (2005) 0.89
Telomere dysfunction in human diseases: the long and short of it! Int J Clin Exp Pathol (2009) 0.89
Production of tannase under solid-state fermentation and its application in detannification of guava juice. Prep Biochem Biotechnol (2014) 0.88
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88
Comparison of results in endovascular interventions for infrainguinal lesions: claudication versus critical limb ischemia. Am Surg (2005) 0.88
An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J Virol (2011) 0.88
Syncope in a middle aged male due to acute rheumatic fever. Indian Heart J (2005) 0.86
Eberconazole--pharmacological and clinical review. Indian J Dermatol Venereol Leprol (2012) 0.86
Traumatic spinal cord injuries. Lancet (2011) 0.86
Internal and external rotation of the shoulder: effects of plane, end-range determination, and scapular motion. J Shoulder Elbow Surg (2005) 0.85
Biological roles and functional mechanisms of arenavirus Z protein in viral replication. J Virol (2012) 0.85
Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses. Antimicrob Agents Chemother (2011) 0.85
Eucommia ulmoides bark protects against renal injury in cadmium-challenged rats. J Med Food (2011) 0.85
Correlation of ultrasonographic parameters with serum creatinine in chronic kidney disease. J Clin Imaging Sci (2013) 0.85
Percutaneous endovascular treatment for chronic limb ischemia. Ann Vasc Surg (2005) 0.84
Usefulness of 16S rDNA sequencing for the diagnosis of infective endocarditis caused by Corynebacterium diphtheriae. J Med Microbiol (2012) 0.84
Identification of virulence determinants within the L genomic segment of the pichinde arenavirus. J Virol (2013) 0.84
Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus. Virology (2012) 0.84
Avian rotavirus enteritis - an updated review. Vet Q (2015) 0.84
3D analysis of breast augmentation defines operative changes and their relationship to implant dimensions. Ann Plast Surg (2009) 0.81
Mammometrics: the standardization of aesthetic and reconstructive breast surgery. Plast Reconstr Surg (2010) 0.81
PLC-γ1 signaling plays a subtype-specific role in postbinding cell entry of influenza A virus. J Virol (2013) 0.81
Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model. PLoS One (2011) 0.80
Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response. Vaccine (2007) 0.80
Maleimide as an efficient nucleophilic partner in the aza-Morita-Baylis-Hillman reaction: synthesis of chiral 3-substituted-3-aminooxindoles. Org Biomol Chem (2015) 0.80
Evaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric study. Vasc Health Risk Manag (2006) 0.79
Multiple vascular variations at the vicinity of the left kidney. Anat Sci Int (2013) 0.79
Identification of TINF2 gene mutations in adult Japanese patients with acquired bone marrow failure syndromes. Br J Haematol (2010) 0.79
Aerosol infection model of tuberculosis in wistar rats. Int J Microbiol (2010) 0.79
Functional characterization of yeast telomerase RNA dimerization. J Biol Chem (2007) 0.79
Defining pseudoptosis (bottoming out) 3 years after short-scar medial pedicle breast reduction. Aesthetic Plast Surg (2010) 0.78
[Comparison of temporomandibular joint injuries after three-dimensional conformal and intensity-modulated radiotherapies for nasopharyngeal carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao (2012) 0.78
Rescue of rubella virus replication-defective mutants using vaccinia virus recombinant expressing rubella virus nonstructural proteins. Virus Res (2002) 0.78
Acellular dermal graft for repair of abdominal wall defects in rabbits. J S Afr Vet Assoc (2006) 0.78
Evaluation of goat based 'indigenous vaccine' against bovine Johne's disease in endemically infected native cattle herds. Indian J Exp Biol (2015) 0.78
Knowledge and Attitude about HIV/AIDS among HIV-Positive Individuals in Davangere. Soc Work Public Health (2015) 0.78
Transcriptional activation of TINF2, a gene encoding the telomere-associated protein TIN2, by Sp1 and NF-κB factors. PLoS One (2011) 0.77
Properties and mutation studies of a bacteriophage-derived chimeric recombinant staphylolytic protein P128: Comparison to recombinant lysostaphin. Bacteriophage (2013) 0.77
Re-defining pseudoptosis from a 3D perspective after short scar-medial pedicle reduction mammaplasty. J Plast Reconstr Aesthet Surg (2008) 0.77
Functional characterization of mutations in the promoter proximal region of the telomerase hTERC gene identified in patients with hematological disorders. Int J Clin Exp Med (2011) 0.77
Evaluation of 'cattle' and 'Indian Bison' type antigens of Mycobacterium avium subspecies paratuberculosis for diagnosis of bovine Johne's disease using 'indigenous ELISA' and AGPT. Indian J Exp Biol (2014) 0.76
Mutational analyses of the influenza A virus polymerase subunit PA reveal distinct functions related and unrelated to RNA polymerase activity. PLoS One (2012) 0.76
A Case of Sinusitis Caused by Schizophyllum Commune and Bacteria in Acute Myelocytic Leukemia. Clin Lab (2015) 0.76
Genome Sequence of the "Indian Bison Type" Biotype of Mycobacterium avium subsp. paratuberculosis Strain S5. Genome Announc (2013) 0.76
Bacterial profile of the oropharynx in infants: an assessment of the confounding factors for colonization. Indian J Pediatr (2011) 0.76